Marc Benioff - 13 Oct 2021 Form 4 Insider Report for SALESFORCE.COM, INC. (CRM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Oct 2021, 17:46:10 UTC
Prior SEC filing
13 Oct 2021
Next SEC filing
15 Oct 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anisha Mehta, Attorney-in-Fact for Marc Benioff

Key filing fact

Marc Benioff filed Form 4 for SALESFORCE.COM, INC. (CRM) on 14 Oct 2021.

Key facts

  • This page summarizes Marc Benioff's Form 4 filing for SALESFORCE.COM, INC. (CRM).
  • 8 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Oct 2021, 17:46.

Change

  • Previous filing in this sequence was filed on 13 Oct 2021.
  • Current net transaction value: -$4,477,982.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRM transaction

Common Stock

Options Exercise

Transaction value
$1,186,800
Shares
+20,000
Change %
+0.07%
Price
$59.34
Shares after
29,006,249
Date
13 Oct 2021
Ownership
Direct
Footnotes
F1, F2
CRM transaction

Common Stock

Sale

Transaction value
$234,254
Shares
-838
Change %
-0%
Price
$279.54
Shares after
29,005,411
Date
13 Oct 2021
Ownership
Direct
Footnotes
F1, F2, F3
CRM transaction

Common Stock

Sale

Transaction value
$84,222
Shares
-300
Change %
-0%
Price
$280.74
Shares after
29,005,111
Date
13 Oct 2021
Ownership
Direct
Footnotes
F1, F2, F4
CRM transaction

Common Stock

Sale

Transaction value
$1,128,538
Shares
-3,997
Change %
-0.01%
Price
$282.35
Shares after
29,001,114
Date
13 Oct 2021
Ownership
Direct
Footnotes
F1, F2, F5
CRM transaction

Common Stock

Sale

Transaction value
$2,461,774
Shares
-8,689
Change %
-0.03%
Price
$283.32
Shares after
28,992,425
Date
13 Oct 2021
Ownership
Direct
Footnotes
F1, F2, F6
CRM transaction

Common Stock

Sale

Transaction value
$1,585,048
Shares
-5,576
Change %
-0.02%
Price
$284.26
Shares after
28,986,849
Date
13 Oct 2021
Ownership
Direct
Footnotes
F1, F2, F7
CRM transaction

Common Stock

Sale

Transaction value
$170,946
Shares
-600
Change %
-0%
Price
$284.91
Shares after
28,986,249
Date
13 Oct 2021
Ownership
Direct
Footnotes
F1, F2, F8

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRM transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-20,000
Change %
-7%
Price
$0.000000
Shares after
266,358
Date
13 Oct 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$59.34
Footnotes
F1, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Footnote F2

Other than the shares subject to the transactions reported in this Form 4 (which are held in the reporting person's name), shares are held in the Marc R. Benioff Revocable Trust.

Footnote F3

Weighted average price. These shares were sold in multiple transactions at prices ranging from $279.1900 to $280.0000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F4

Weighted average price. These shares were sold in multiple transactions at prices ranging from $280.3100 to $281.1200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F5

Weighted average price. These shares were sold in multiple transactions at prices ranging from $281.7700 to $282.7600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F6

Weighted average price. These shares were sold in multiple transactions at prices ranging from $282.8300 to $283.7600 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F7

Weighted average price. These shares were sold in multiple transactions at prices ranging from $283.8300 to $284.8200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F8

Weighted average price. These shares were sold in multiple transactions at prices ranging from $284.8300 to $284.9900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F9

Option vests over four years at the rate of 25% on November 25, 2015, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .